Creating a Paradigm for Biomarker Testing

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. Goeffrey Oxnard and Lauren Ritterhouse consider the advantages and disadvantages of liquid biopsies as an early screening tool for biomarker testing, and how to integrate various approaches into a biomarker testing paradigm.

July 29, 2015

How to Improve the Cost of Cancer Treatments

Dr. Alex Adjei addresses the high cost of cancer medicines and suggests various ways to improve cost-effectiveness.

April 14, 2015

The bioT3 Platform

Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.